For dulaglutide (Trulicity) and tirzepatide (Mounjaro, Zepbound), at least 72 hours (3 days) must elapse between doses
Starting January 1, 2025, Kaiser Permanente plans to exclude coverage for GLP-1 medications when prescribed exclusively for reducing body mass in patients with a BMI under 40
It causes an immediate release of almost all the granules (containing serotonin, histamine, chemokines, cytokines, enzymes, heparin, and prostaglandins), which trigger itching, swelling, mucous, and anaphylaxis.[ref] A delayed response by mast cells comes from the formation of other mediators, such as prostaglandin D2
Ub and Dub of RNF43/ZNRF3 in the WNT signalling pathway